HeartSciences Statistics

Total Valuation

HeartSciences has a market cap or net worth of $4.50 million. The enterprise value is $4.89 million.

Market Cap	4.50M
Enterprise Value	4.89M

Important Dates

The next estimated earnings date is Monday, July 28, 2025, after market close.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HeartSciences has 1.08 million shares outstanding. The number of shares has increased by 290.34% in one year.

Current Share Class	1.08M
Shares Outstanding	1.08M
Shares Change (YoY)	+290.34%
Shares Change (QoQ)	+7.48%
Owned by Insiders (%)	7.88%
Owned by Institutions (%)	7.70%
Float	995,740

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.40
P/TBV Ratio	25.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.67.

Current Ratio	1.02
Quick Ratio	0.73
Debt / Equity	1.67
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.41

Financial Efficiency

Return on equity (ROE) is -163.47% and return on invested capital (ROIC) is -71.82%.

Return on Equity (ROE)	-163.47%
Return on Assets (ROA)	-62.95%
Return on Invested Capital (ROIC)	-71.82%
Return on Capital Employed (ROCE)	-389.77%
Revenue Per Employee	n/a
Profits Per Employee	-$567,804
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.88% in the last 52 weeks. The beta is 2.59, so HeartSciences's price volatility has been higher than the market average.

Beta (5Y)	2.59
52-Week Price Change	-5.88%
50-Day Moving Average	3.74
200-Day Moving Average	3.48
Relative Strength Index (RSI)	52.49
Average Volume (20 Days)	143,359

Short Selling Information

The latest short interest is 192,283, so 17.79% of the outstanding shares have been sold short.

Short Interest	192,283
Short Previous Month	79,096
Short % of Shares Out	17.79%
Short % of Float	19.31%
Short Ratio (days to cover)	1.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.31M
Pretax Income	-6.61M
Net Income	-8.52M
EBITDA	-8.27M
EBIT	-8.31M
Earnings Per Share (EPS)	-$10.22

Full Income Statement

Balance Sheet

The company has $2.60 million in cash and $2.99 million in debt, giving a net cash position of -$390,557 or -$0.36 per share.

Cash & Cash Equivalents	2.60M
Total Debt	2.99M
Net Cash	-390,557
Net Cash Per Share	-$0.36
Equity (Book Value)	1.79M
Book Value Per Share	1.73
Working Capital	57,632

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.40 million and capital expenditures -$51,956, giving a free cash flow of -$7.45 million.

Operating Cash Flow	-7.40M
Capital Expenditures	-51,956
Free Cash Flow	-7.45M
FCF Per Share	-$6.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HeartSciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-290.34%
Shareholder Yield	-290.34%
Earnings Yield	-189.41%
FCF Yield	-165.70%

Analyst Forecast

The average price target for HeartSciences is $13.00, which is 212.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	212.50%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 17, 2024. It was a reverse split with a ratio of 0.01:1.

Last Split Date	May 17, 2024
Split Type	Reverse
Split Ratio	0.01:1

Scores

HeartSciences has an Altman Z-Score of -22.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.29
Piotroski F-Score	1